CSIMarket Company Name, Ticker, Industry, else..
 
Inogen Inc   (NASDAQ: INGN)
Other Ticker:  
 
 
Price: $6.4800 $0.23 3.680%
Day's High: $6.82 Week Perf: -2.11 %
Day's Low: $ 6.47 30 Day Perf: 10.2 %
Volume (M): 290 52 Wk High: $ 13.33
Volume (M$): $ 1,877 52 Wk Avg: $9.08
Open: $6.53 52 Wk Low: $5.70



 Market Capitalization (Millions $) 163
 Shares Outstanding (Millions) 25
 Employees 1,094
 Revenues (TTM) (Millions $) 340
 Net Income (TTM) (Millions $) -27
 Cash Flow (TTM) (Millions $) 15
 Capital Exp. (TTM) (Millions $) 4

Inogen Inc
Inogen Inc is a medical device company that specializes in the development and manufacturing of portable oxygen concentrators (POCs) for patients suffering from respiratory diseases such as chronic obstructive pulmonary disease (COPD), emphysema, and pulmonary fibrosis.
The company was founded in 2001 and is headquartered in Goleta, California.
Inogen's POCs are designed to provide patients with greater mobility, independence, and quality of life.
Unlike traditional oxygen therapy methods such as oxygen cylinders, Inogen's POCs are lightweight, compact, and can be worn on the patient's body, allowing them to travel and participate in daily activities without being constrained by bulky equipment.
In addition to POCs, the company also offers a range of accessories such as replacement batteries, carrying cases, and extra cannulas.
Inogen's products are sold directly to patients as well as through a network of authorized dealers and distributors in the US and internationally.
Inogen's innovative products and focus on patient needs have earned it numerous awards and accolades, including being named one of Forbes' "Most Innovative Growth Companies" and Medical Design Briefs' "2016 Medical Product of the Year."


   Company Address: 859 Ward Drive Goleta 93111 CA
   Company Phone Number: 562-0500   Stock Exchange / Ticker: NASDAQ INGN


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ELMD        1.26% 
PROF        13.74% 
AHCO   -2.49%    
AMED        3.12% 
FPH   -1.08%    
• View Complete Report
   



Stocks on the Move

Inogen, Inc. (NASDAQ INGN), a key player in the medical technology sector, has garnered significant attention following its impressive second-quarter earnings report r...

Published Thu, Aug 15 2024 8:28 AM UTC

Inogen s Strong Q2 Performance Boosts Market Confidence: Shares Surge 25% Inogen, Inc. (NASDAQ: INGN), a key player in the medical technology sector, has garnered significant attention following its impressive second-quarter earnings report released on August 6, 2024. The company reported earnings per share (EPS) of $-0.24, easily surpassing analysts expectations, which had...
Inogen Inc

Inogen Inc. Faces Challenging Times as Revenue Takes a Dismal -20.3% Dive in Q3 2023


to Inogen Inc and Industry Outlook
Inogen Inc (INGN) is a leading player in the Medical Equipment & Supplies sector. However, the company recently reported a significant rise in losses for the fiscal three months ending September 30, 2023. Weak orders have been identified as the primary factor behind this decline, resulting in a shortfall per share that surged to $-1.97 from $-0.42. Additionally, the quarter witnessed a sharp decline in revenue, down by -20.327% to $83.97 million from $105.39 million in the same period the previous year.
Contrasting Performance with the Industry
Interestingly, the Medical Equipment & Supplies sector as a whole recorded a revenue increase of 4.89% in the third quarter of 2023. This contrasted with Inogen Inc's decline, highlighting the company's unique challenges amid the industry's growth. These numbers provide crucial insights for investors to consider, as they indicate the fluctuating fortunes of individual companies within a sector.
Inogen Inc

Inogen Inc's Financial Health Plunges: Plummeting Revenues, Soaring Losses, and Market Struggles Threaten Medical Device Giant's Future



Inogen Inc, a leading provider of medical devices, has recently reported concerning financial results for the fiscal second quarter of 2023. With deteriorating deficits, declining revenues, and substantial losses, the company is struggling to maintain a stable position in the market. Coupled with a drop in stock performance and a weak year-to-date performance, these financial indicators paint a bleak picture for the company's future prospects.
Widened Deficit and Escalating Losses:
Ingen Inc's deficit has experienced a significant widening, with a staggering $0.42 per share deficit in the fiscal second quarter of 2023, compared to $0.15 per share in the same period a year ago. Furthermore, the net loss for the quarter amounted to $9.826 million, showing a steep increase from $3.442 million reported a year prior. These alarming figures highlight the company's inability to control costs and generate sufficient revenue to support its operations.
Inogen Inc

Inogen Inc faces significant challenges during demanding Q1 2023, but shows improvement in key financial metrics

Inogen Inc is a biomedical company headquartered in Goleta, California that specializes in the development and manufacture of portable oxygen concentrators. The company's main focus is on improving the quality of life for those who require oxygen therapy, especially for patients with chronic obstructive pulmonary disease (COPD). Inogen was founded in 2001 by Alison Bauerlein, Brenton Taylor, and Byron Myers.
The financial first quarter of 2023 INGN Deficit has extended of $-0.88 per share compared to $-0.62 a year prior. However, EPS improved from $-2.47 per share in the prior financial reporting period. The company experienced a respectable recession of -10.23% in revenue in the financial first quarter of 2023, generating $72.16 million in comparison to the $80.39 million in the same financial reporting period the previous year. Sequentially revenue fell by -18.082% from $88.09 million.






Inogen Inc's Segments
U S revenue    61.13 % of total Revenue
Non-U S revenue    38.87 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com